Related Experiment Video
Updated: Jun 23, 2026
08:34
Precise Visualization of Insulin Receptors A and B in Murine Brain with an RNA In Situ Hybridization Assay
Published on: July 15, 2025
IGF2 mRNA-binding protein 2: biological function and putative role in type 2 diabetes
Jan Christiansen1, Astrid M Kolte, Thomas v O Hansen
1Department of Biology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Journal of Molecular Endocrinology
|May 12, 2009
Summary
Genome-wide studies link IGF2 mRNA-binding protein 2 (IMP2) to type 2 diabetes. This review examines IMP2
Area of Science:
- Molecular Biology
- Genetics
- Endocrinology
Background:
- IGF2 mRNA-binding protein 2 (IMP2) is an oncofetal protein involved in RNA processing.
- IMP2 plays critical roles in embryonic development through RNA localization, stability, and translation.
- IMP2 belongs to a family of proteins with essential functions in cellular processes.
Purpose of the Study:
- To provide a background on the IMP protein family, focusing on human IMP2.
- To review genome-wide association (GWA) studies investigating the link between IMP2 and type 2 diabetes (T2D).
- To evaluate the significance of the proposed correlation between IMP2 and T2D.
Main Methods:
- Literature review of GWA studies.
- Analysis of the role of IMP2 in RNA metabolism.
- Examination of IMP2's function in embryonic development.
Main Results:
- GWA studies suggest IMP2 is implicated in the etiology of late-onset type 2 diabetes.
- IMP2's functions in RNA regulation are crucial for normal development.
- Evidence for a direct correlation between IMP2 and T2D requires further investigation.
Conclusions:
- IMP2 is a potential factor in the development of type 2 diabetes.
- Understanding IMP2's role in RNA processing may offer insights into T2D pathogenesis.
- Further research is needed to elucidate the precise mechanisms linking IMP2 to T2D.
Related Concept Videos
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...